Clinical Trials Sponsored by Emanuele Bosi

Total 235 results

Emanuele Bosi

Terminated

Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients (INTERCOP)

COVID-19 Virus Infection

Italy
Emanuele Bosi
Italian Diabetes Foundation

Completed

Universal Capillary Screening for Chronic Autoimmune, Metabolic and Cardiovascular Diseases: Feasibility and Acceptability Pilot Study. (UNISCREEN)

Autoimmune Diseases | Cardiovascular Risk Factors

Italy
Emanuel Amier Diekmann

Unknown

Osteopathy and Latent Hypothyroidism

Latent Hypothyroidism
Azienda Ospedaliera, Universitaria Policlinico...

Not yet recruiting

Vital Root Amputation in Molars With Advanced Periodontal Furcation Involvement: a Preliminary Study

Periodontal Diseases | Furcation Defects

Italy
Nick Emanuele

Withdrawn

The Effects of Tranexamic Acid on Blood Loss During Orthognathic Surgery (TXA-OMFS)

Orthognathic Surgery | Tranexamic Acid

Canada
Azienda Ospedaliera, Universitaria Policlinico...

Completed

NAFLD: Independent Effects of Western Dietary Pattern Profile and Sedentary Life (ct-NAFLD)

Fatty Liver
Azienda Ospedaliera, Universitaria Policlinico...

Completed

Microbiota Around Periodontal Teeth and Implants Affected by Peri-implant Disease.

Periodontal Diseases | Peri-Implantitis

Italy
Azienda Ospedaliera, Universitaria Policlinico...

Unknown

Ultrasound Emergency Diagnosis of Small Bowel Obstruction (USBOW)

Obstruction Bowel
Azienda Ospedaliera, Universitaria Policlinico...

Completed

Echocardiography, Adherence to Mediterranean Diet (AMDS) and Physical Exercise in Fatty Liver (CARDIONAFLD)

Fatty Liver

Italy
Emanuela Keller

Completed

Neuro-COVID-19: Neurological Complications of COVID-19 (Neuro-COVID)

Neurologic Complication

Switzerland
Emanuela Keller

Suspended

ICU Cockpit Apps: Interventional Study With First ICU Cockpit Software Applications (ICUCockpitApp)

Clinical Decision Support System

Switzerland
Université NAZI BONI

Not yet recruiting

Effects of Perioperative Administration of Intravenous Lidocaine in Children Operated on for Acute Generalized Peritonitis

Postoperative Pain
Université NAZI BONI

Completed

Opioid Free Anesthesia in Maxillofacial Surgery

Maxillofacial Surgery

Burkina Faso
Université NAZI BONI

Completed

Transverse Abdominal Plane Block for Caesarean

Caesarean Section; Pain

Burkina Faso
Emanuela Keller

Recruiting

Functional Near-infrared Spectroscopy in Unconscious Patients (fNIRS)

Nervous System Diseases | Healthy Subjects

Switzerland
OSI Pharmaceuticals

Completed

A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer

Locally Advanced or Metastatic Adenoca of the Biliary Tract

United States, Belgium, Germany, Poland, Romania, Switzerland
Azienda Ospedaliera, Universitaria Policlinico...
Marinella Astuto

Recruiting

Spinal Anesthesia in Caesarean Section

Bradycardia | Cesarean Section Complications | Hypotension Drug-Induced | Spinal Anesthetics Causing Adverse Effects in Therapeutic Use

Italy
OSI Pharmaceuticals

Completed

Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors

Advanced Solid Tumors

United States
OSI Pharmaceuticals

Completed

A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy

Locally Recurrent or Metastatic Cancer of the Head and Neck | Must Have Failed First-Line Therapy

United States
OSI Pharmaceuticals

Completed

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

Gastric Adenocarcinoma | Gastroesophageal Adenocarcinoma

United States, United Kingdom, Belgium
Emanuela Valsangiacomo

Completed

Clinical Evaluation of 4D Flow Cardiac MRI Sequences (Eval-4DFlow)

Indication, Unlabeled
Duke University
BOSE Corporation

Completed

Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD

ADHD

United States
Emanuel Trabuco
American Medical Systems

Terminated

The ELEGANT Trial: Elevate Transvaginal Mesh vs. Anterior Colporrhaphy

Pelvic Organ Prolapse

United States, Germany
Emmanuel Boselli

Completed

Prediction of Immediate Postoperative Pain Using Analgesia/Nociception Index (ANI)

Postoperative Pain

France
Guglielmo Trovato, MD, PhD

Completed

Emergency Thoracic Ultrasound and Clinical Risk Management (CLINRISKETUS)

Chest Disorders
Emmanuel Boselli

Completed

Prediction of Hemodynamic Reactivity During Suspension Laryngoscopy Using Analgesia/Nociception Index (ANI)

Anesthesia

France
Emanuela Keller
CytoSorbents Europe GmbH

Terminated

CytoSorb SAH Trial

Aneurysmal Subarachnoid Haemorrhage

Switzerland
Mayo Clinic
OSI Pharmaceuticals

Completed

Exisulind Versus Placebo After Surgical Removal of the Prostate

Prostatic Neoplasms

United States
Emory University
OSI Pharmaceuticals

Terminated

A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancer

Liver Cancer

United States
Azienda Ospedaliera, Universitaria Policlinico...
Ospedale Civile di Ragusa, Italy

Completed

CRP and Thoracic Emergency Ultrasound in Pneumonia (TUS-STRAT)

Ultrasound | Community-acquired Pneumonia | Difference, Individual

Italy
Indiana University
OSI Pharmaceuticals

Completed

Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

Leukemia, Myelomonocytic, Acute

United States
Northwestern University
OSI Pharmaceuticals

Withdrawn

Erlotinib for Treatment of Psoriasis

Psoriasis

United States
Emory University
OSI Pharmaceuticals

Withdrawn

A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies

Neoplasms | Cancer | Tumors

United States
Manuela Eicher

Recruiting

ePRO-based Model of Care to Manage and Monitoring Symptoms of Cancer Patients Treated With Immune Checkpoint Inhibitors (IePRO)

Patient Reported Outcome Measures | Patient Safety

Switzerland
ASST Fatebenefratelli Sacco
Tommaso Fossali; Beatrice Borghi; Emanuele Catena; Andrea Perotti

Completed

Evaluation of a Model for Post-Anesthesia Troponin Increase and Heart Injury EStimation (EMPATHIES)

Postoperative Myocardial Ischemia

Italy
Hospital de Rehabilitacion Manuel Rocca

Completed

The Weighting of the Balance

Physical Therapy | Survey | Balance | Assessment

Argentina
University of Arkansas
OSI Pharmaceuticals

Terminated

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Metastatic Breast Cancer

United States
OSI Pharmaceuticals

Terminated

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma (PETEY)

Recurrent or Refractory Pediatric Ependymoma

United States, Canada, United Kingdom
OSI Pharmaceuticals

Terminated

Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205

Ependymoma

United States, Canada, United Kingdom
OSI Pharmaceuticals

Completed

A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function

Advanced Solid Tumors

United States, United Kingdom
NYU Langone Health
OSI Pharmaceuticals

Terminated

Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer

Ovarian Cancer

United States
Hospital de Rehabilitacion Manuel Rocca

Active, not recruiting

Cross-cultural Adaptation and Validity of Mini Bestest in Balance Disorders in the Autonomous City of Buenos Aires: Validation Study Protocol

Vestibular Disease | Peripheral Vestibular Disorder

Argentina
University of Oklahoma
OSI Pharmaceuticals

Terminated

Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera (OSI-TAR-766)

Polycythemia Vera

United States
OSI Pharmaceuticals

Completed

A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors (RADIANT)

Non-small Cell Lung Cancer

United States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
OSI Pharmaceuticals

Completed

Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2

Non-Small Cell Lung Cancer

United States
OSI Pharmaceuticals

Completed

Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC

Carcinoma, Non-Small-Cell Lung

United States, United Kingdom
OSI Pharmaceuticals

Completed

A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

NSCLC

United Kingdom, United States
Astellas Pharma Inc
OSI Pharmaceuticals

Completed

Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer

SCLC | Carcinoma, Small Cell

United Kingdom, United States
Astellas Pharma Inc
OSI Pharmaceuticals

Completed

Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer

Ovarian Neoplasms

United Kingdom, United States

Clinical Trials Sponsored by Emanuele Bosi

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations